|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/68 | (2006.01) |
| A01K 67/027 | (2006.01) | ||
| A61K 38/00 | (2006.01) | ||
| C07K 16/18 | (2006.01) | ||
| C12N 15/85 | (2006.01) | ||
| A61K 49/00 | (2006.01) |
| (11) | Number of the document | 2272539 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10006457.5 |
| Date of filing the European patent application | 2005-10-19 | |
| (97) | Date of publication of the European application | 2011-01-12 |
| (45) | Date of publication and mention of the grant of the patent | 2014-03-05 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 969335 | 2004-10-19 | US | |
| 194115 | 2005-07-29 | US |
| (72) |
Chilcote, Tamie J., US
Goldstein, Jason, US
Anderson, John P., US
Walker, Donald, US
|
| (73) |
Elan Pharmaceuticals, LLC,
300 Technology Square, Third Floor, Cambridge, MA,
US
|
| (54) | Truncated fragments of alpha-synuclein in lewy body disease |
| Truncated fragments of alpha-synuclein in lewy body disease |